KALA
USDKALA BIO Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$0.740
Kõrge
$0.800
Madal
$0.740
Maht
0.08M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
5.3M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.11M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
HC Wainwright & Co. Maintains Buy on Kala Bio, Raises Price Target to $35
HC Wainwright & Co. analyst Yi Chen maintains Kala Bio with a Buy and raises the price target from $12 to $35.
Oppenheimer Maintains Outperform on Kala Bio, Raises Price Target to $33
Oppenheimer analyst Andreas Argyrides maintains Kala Bio with a Outperform and raises the price target from $15 to $33.
Mizuho Initiates Coverage On Kala Bio with Outperform Rating, Announces Price Target of $30
Mizuho analyst Graig Suvannavejh initiates coverage on Kala Bio with a Outperform rating and announces Price Target of $30.
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for
Seotud aktsiad
ULCC
Frontier Group Holdings Inc.
GOODN
Gladstone Commercial Corporation 6.625% Series E Cumulative Redeemable Preferred Stock
RFL
Rafael Holdings Inc.
GBBKW
Global Blockchain Acquisition Corp. Warrant
SUM
Summit Materials Inc.
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.